ALX ONCOLOGY HOLDINGS INC (ALXO) › Operating Cash FlowALX ONCOLOGY HOLDINGS INC (ALXO) — Operating Cash FlowAnnual figures by fiscal year, from SEC filings.2018: -$13.19M2019: -$14.25M2020: -$38.29M2021: -$68.10M2022: -$89.22M2023: -$130.36M2024: -$121.91M2025: -$84.14M-$84.14M2018Operating Cash Flow (USD)2025Fiscal YearOperating Cash FlowChange YoY2025-$84.14M+31.0%2024-$121.91M+6.5%2023-$130.36M-46.1%2022-$89.22M-31.0%2021-$68.10M-77.9%2020-$38.29M-168.7%2019-$14.25M-8.0%2018-$13.19M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsCapital ExpendituresShares OutstandingDividends Per Share